Try our Advanced Search for more refined results

Takeda Tells Jury Studies Tying Actos To Cancer Are Flawed

By Brandon Lowrey (August 28, 2015, 6:20 PM EDT) -- An attorney for Takeda Pharmaceutical Co. Ltd. on Friday told jurors that two men who developed bladder cancer after taking the company's diabetes drug Actos rely on second-rate science in their bid to link the medication to their ailments, adding that both men had other risk factors including tobacco use....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!